Skip to content

Sleep Disturbance in Deployed Soldiers

Sleep Disturbance in Deployed Soldiers

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00860756
Enrollment
150
Registered
2009-03-12
Start date
2007-09-30
Completion date
2009-07-31
Last updated
2009-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disturbance

Keywords

sleep, disturbance, deployment, intervention, actigraph

Brief summary

Hypotheses: * Hypothesis 1 - Sleep can be measured in Theater using actigraph technology. * Hypothesis 2 - Standard sleep measures in Soldiers randomized to a sleep intervention group will more closely approximate normal as compared to sleep measures of Soldiers randomized to the control group.

Interventions

A music CD specifically created for this study to promote effective sleep while deployed. It includes sleep instructions tailored to the military deployment environment. The CD includes a voice directed meditation component that helps focus the listener on relaxation in preparation for sleep. The second track is specifically designed music to promote slow breathing and induce sleep.

Sponsors

Brooke Army Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* All study participants must be on Active Duty, or be Reserve or National Guard Service Members notified of impending deployment. * Recruited prior to deployment in order to obtain baseline measures before deployment. * Have been stateside at least one full year. * Able to read and speak English and consent themselves.

Exclusion criteria

* Subjects with self-identified sleep disorder (for example restless leg syndrome or sleep apnea) * Pregnancy. Pregnant women will be excluded from the study since pregnancy places women in a non-deployable status and pregnant Soldiers will not be deploying.

Design outcomes

Primary

MeasureTime frame
Actigraph and self report questionnairesbaseline, 6 months, 18 months

Secondary

MeasureTime frame
Self report questionnairesbaseline, 6 months, 18 months

Countries

United States

Contacts

Primary ContactMona O. Bingham, PhD
mona.bingham@amedd.army.mil(210) 916-7159
Backup ContactStacey Young-McCaughan, PhD
stacey.young-mccaughan@us.army.mil(210) 567-1942

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026